| Literature DB >> 29738093 |
Shigeo Negi1, Daisuke Koreeda1, Sou Kobayashi1, Takuro Yano1, Koichi Tatsuta1, Toru Mima1, Takashi Shigematsu1, Masaki Ohya1.
Abstract
Acute kidney injury (AKI) is one of the most common serious complications for all hospital admissions, with its incidence increasing among hospitalized patients, particularly those in the intensive care unit. Despite significant improvements in critical care and dialysis technology, AKI is associated with an increased risk of short- and long-term mortality, prolonged hospital stays, and dialysis dependence. These risks are particularly relevant for critically ill patients with AKI severe enough to require renal replacement therapy (RRT). No specific pharmacologic treatment has been established to treat AKI. Hence, the mainstay treatment for patients with AKI is RRT even though there are still several problematic issues regarding its use including RRT modality, dose, and timing. Recently, the impact of AKI on an increased risk of progression to chronic kidney disease (CKD) and end-stage renal disease requiring dialysis or transplantation is attracting increased attention.Entities:
Mesh:
Year: 2018 PMID: 29738093 DOI: 10.1111/sdi.12705
Source DB: PubMed Journal: Semin Dial ISSN: 0894-0959 Impact factor: 3.455